Clinical Practice

Use the tool below to view all available Global Neurology Academy Series

Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
NeuroFrontiers
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
- Ahmed Abdelhak, MD
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
NeuroFrontiers
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
- Mary Rensel, MD, FAAN, ABIHM
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiers
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiers
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- Maxwell H. Levy, MD
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
NeuroFrontiers
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
- Jerome Lisk, MD, MBA, M.S., FAAN
- Emile Maamary
- Mark Elias
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiers
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
- Rosaline Quinlivan
The Complexities of DMD: Optimizing Multidisciplinary Care
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiers
The Complexities of DMD: Optimizing Multidisciplinary Care
- Rosaline Quinlivan
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiers
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
Global Neurology Academy
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
- Marisa McGinley, DO
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Global Neurology Academy
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD